Gut microbiota and the role of probiotics in therapy

Current Opinion in Pharmacology

Volumn 11, Issue 6, 2011, Pages 593-603

  Quigley, Eamonn M ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PLACEBO; PROBIOTIC AGENT;

ABSCESS; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTEROIDES FRAGILIS; BIFIDOBACTERIUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM LONGUM INFANTIS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNICABLE DISEASE; DRUG EFFICACY; DRUG SAFETY; ENDOCARDITIS; ENTERITIS; ENTEROCOCCUS FAECALIS; FAECALOBACTERIUM PRASUNITZII; FERMENTATION; GASTROINTESTINAL DISEASE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HOST; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFECTIOUS DIARRHEA; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS BULGARICUS; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LACTOBACILLUS SALIVARIUS; LIVER DISEASE; METAGENOME; MICROBIAL ACTIVITY; MICROBIAL DIVERSITY; MICROBIOME; MYCOBACTERIUM PARATUBERCULOSIS; NONHUMAN; OBESITY; ORGANISMAL INTERACTION; PANCREAS DISEASE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; ROTAVIRUS INFECTION; SACCHAROMYCES BOULARDII; SALMONELLA TYPHIMURIUM; SEPSIS; SEPTICEMIA;

EID: 82255162672     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.09.010     Document Type: Review

References (152)

1. M.J. Claesson, S. Cusack, O. O'Sullivan, R. Greene-Diniz, H. de Weerd, E. Flannery, J.R. Marchesi, D. Falush, T. Dinan, and G. Fitzgerald Composition, variability, and temporal stability of the intestinal microbiota of the elderly Proc Natl Acad Sci USA 108 Suppl. 1 2011 4586 4591
2. Human Microbiome Jumpstart Reference Strains Consortium, K.E. Nelson, G.M. Weinstock, S.K. Highlander, K.C. Worley, H.H. Creasy, J.R. Wortman, D.B. Rusch, M. Mitreva, and E. Sodergren A catalog of reference genomes from the human microbiome Science 328 2010 994 999
3. J. Qin, R. Li, J. Raes, M. Arumugam, K.S. Burgdorf, C. Manichanh, T. Nielsen, N. Pons, F. Levenez, and T. Yamada A human gut microbial gene catalogue established by metagenomic sequencing Nature 464 2010 59 65
4. B.V. Jones, F. Sun, and J.R. Marchesi Comparative metagenomic analysis of plasmid encoded functions in the human gut microbiome BMC Genomics 11 2010 46
5. B.V. Jones, M. Begley, C. Hill, C.G. Gahan, and J.R. Marchesi Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome Proc Natl Acad Sci USA 105 2008 13580 13585
6. M.J. Claesson, and P.W. O'Toole Evaluating the latest high-throughput molecular techniques for the exploration of microbial gut communities Gut Microbes 1 2010 277 278
7. M. Cronin, R.D. Sleator, C. Hill, G.F. Fitzgerald, and D. van Sinderen Development of a luciferase-based reporter system to monitor Bifidobacterium breve UCC2003 persistence in mice BMC Microbiol 8 2008 161
8. S.A. Frese, A.K. Benson, G.W. Tannock, D.M. Loach, J. Kim, M. Zhang, P.L. Oh, N.C.K. Heng, P.B. Patil, and N. Juge The evolution of host specialization in the vertebrate gut symbiont Lactobacillus reuteri PLoS Genetics 7 2011 e1001314
9. M. Roberfroid, G.R. Gibson, L. Hoyles, A.L. McCartney, R. Rastall, I. Rowland, D. Wolvers, B. Watzl, H. Szajewska, and B. Stahl Prebiotic effects: metabolic and health benefits Br J Nutr 104 Suppl. 2 2010 S1 S63
10. Y. Bouhnik, L. Raskine, G. Simoneau, E. Vicaut, C. Neut, B. Flourie, F. Brouns, and F.R. Bornet The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: a double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study Am J Clin Nutr 80 2004 1658 1664 (Pubitemid 41103868)
11. T. Vanhoutte, V. De Preter, E. De Brandt, K. Verbeke, J. Swings, and G. Huys Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii Appl Environ Microbiol 72 2006 5990 5997 (Pubitemid 44414627)
12. Y. Bouhnik, B. Flourie, L. D'Agay-Abensour, P. Pochart, G. Gramet, M. Durand, and J.-C. Rambaud Administration of transgalacto-oligosaccharides increases fecal Bifidobacteria and modifies colonic fermentation metabolism in health humans J Nutr 127 1997 444 448 (Pubitemid 27119998)
13. F. Guarner, and J.R. Malagelada Gut flora in health and disease Lancet 361 2003 512 519 (Pubitemid 36173720)
14. Y.K. Lee, and S.K. Mazmanian Has the microbiota played a critical role in the evolution of the adaptive immune system? Science 330 2010 1768 1773
15. P.B. Eckburg, E.M. Bik, C.N. Bernstein, E. Purdom, L. Dethlefsen, M. Sargent, S.R. Gill, K.E. Nelson, and D.A. Relman Diversity of the human microbial flora Science 308 2005 1635 1638
16. M. Arumugam, J. Raes, E. Pelletier, D. Le Paslier, T. Yamada, D.R. Mende, G.R. Fernandes, J. Tap, T. Bruls, and J.M. Batto Enterotypes of the human gut microbiome Nature 473 2011 174 180
17. R.M. Patel, and P.W. Lin Developmental biology of gut-probiotic interaction Gut Microbes 1 2010 186 195
18. P.G. Falk, L.V. Hooper, T. Midtvedt, and J.I. Gordon Creating and maintaining the gastrointestinal ecosystem: what we know and need to know about gnotobiology Microbiol Mol Biol Rev 62 1998 1157 1170 (Pubitemid 28558295)
19. A. Uribe, M. Alam, O. Johansson, T. Midtvedt, and E. Theodorsson Microflora modulates endocrine cells in the gastrointestinal mucosa of the rat Gastroenterology 107 1994 1259 1269 (Pubitemid 24328261)
20. S.K. Mazmanian, C.H. Liu, A.O. Tzianabos, and D.L. Kasper An immunomodualtory molecule of symbiotic bacteria directs maturation of the host immune system Cell 122 2005 107 118 (Pubitemid 40977944)
21. R. Medzhitov Origin and physiological roles of inflammation Nature 452 2008 428 435
22. S. Lebeer, J. Vanderleyden, and S.C. De Keersmaecker Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens Nat Rev Microbiol 8 2010 171 184
23. A.S. Neish, A.T. Gewirtz, H. Zeng, A.N. Young, M.E. Hobert, V. Karmali, A.S. Rao, and J.L. Madara Prokaryotic regulation of epithelial responses by inhibition of IκB-α ubiquitination Science 289 2000 1560 1563
24. J.L. Round, S.M. Lee, J. Li, G. Tran, B. Jabri, T.A. Chatila, and S.K. Mazmanian The Toll-like receptor 2 pathway establishes colonization by a commensal of the human microbiota Science 332 2011 974 977
25. Y. Wang, S. Devkota, M.W. Musch, B. Jabri, C. Nagler, D.A. Antonopoulos, A. Chervonsky, and E.B. Chang Regional mucosa-associated microbiota determine physiological expression of TLR2 and TLR4 in murine colon PLoS ONE 5 2010 e13607
26. C. O'Mahony, P. Scully, D. O'Mahony, S. Murphy, F. O'Brien, A. Lyons, G. Sherlock, J. MacSharry, B. Kiely, and F. Shanahan Commensal-induced regulatory T cells mediate protection against pathogen-stimulated NF-kappaB activation PLoS Pathog 4 2008 e1000112
27. C. Pagnini, R. Saeed, G. Bamias, K.O. Arseneau, T.T. Pizarro, and F. Cominelli Probiotics promote gut health through stimulation of epithelial innate immunity Proc Natl Acad Sci USA 107 2010 454 459
28. F. Shanahan The host-microbe interface within the gut Best Pract Res Clin Gastroenterol 16 2002 915 931
29. S.C. Corr, Y. Li, C.U. Riedel, P.W. O'Toole, C. Hill, and C.G. Gahan Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118 Proc Natl Acad Sci USA 104 2007 7617 7621 (Pubitemid 47185955)
30. M.C. Rea, C.S. Sit, E. Clayton, P.M. O'Connor, R.M. Whittal, J. Zheng, J.C. Vederas, R.P. Ross, and C. Hill Thuricin CD, a posttranslationally modified bacteriocin with a narrow spectrum of activity against Clostridium difficile Proc Natl Acad Sci USA 107 2010 9352 9357
31. A.M. O'Hara, and F. Shanahan Gut microbiota: mining for therapeutic potential Clin Gastroenterol Hepatol 5 2007 274 284 (Pubitemid 46401524)
32. I. Castagliuolo, M.F. Riegler, L. Valenick, J.T. LaMont, and C. Pothoulakis Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa Infect Immun 67 1999 302 307 (Pubitemid 29021663)
33. C.M. Thomas, and J. Versalovic Probiotics-host communication: modulation of signaling pathways in the intestine Gut Microbes 1 2010 148 163
34. H. Qin, Z. Zhang, X. Hang, and Y. Jiang L. plantarum prevents Enteroinvasive Escherichia coli-induced tight junction protein changes in intestinal epithelial cells BMC Microbiol 9 2009 63
35. S. Resta-Lenert, and K.E. Barrett Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC) Gut 52 2003 988 997 (Pubitemid 36765291)
36. A. Lyons, D. O'Mahony, F. O'Brien, J. MacSharry, B. Sheil, M. Ceddia, W.M. Russell, P. Forsythe, J. Bienenstock, and B. Kiely Bacterial strain-specific induction of Foxp3+ T regulatory cells is protective in murine allergy models Clin Exp Allergy 40 2010 811 819
37. S. Sibartie, A.M. O'Hara, J. Ryan, A. Fanning, J. O'Mahony, S. O'Neill, B. Sheil, L. O'Mahony, and F. Shanahan Modulation of pathogen-induced CCL20 secretion from HT-29 human intestinal epithelial cells by commensal bacteria BMC Immunol 10 2009 54
38. J. McCarthy, L. O'Mahony, and L. O'Callaghan Double-blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokines Gut 52 2003 975 980 (Pubitemid 36765289)
39. L. O'Mahony, L. O'Callaghan, J. McCarthy, D. Shilling, P. Scully, S. Sibartie, E. Kavanagh, W.O. Kirwan, H.P. Redmond, and J.K. Collins Differential cytokine response from dendritic cells to commensal and pathogenic bacteria in different lymphoid compartments in humans Am J Physiol Gastrointest Liver Physiol 290 2006 G839 G845
40. D. Rachmilewitz, Katakura, F. Karmeli, T. Hayashi, C. Reinus, B. Rudensky, S. Akira, K. Takeda, J. Lee, K. Takabayashi, and E. Raz Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis Gastroenterology 126 2004 520 528 (Pubitemid 38182309)
41. H. Jijon, J. Backer, H. Diaz, H. Yeung, D. Thiel, C. McKagney, C. De Simone, and K. Madsen DNA from probiotic bacteria modulates murine and human epithelial and immune function Gastroenterology 126 2004 1358 1373 (Pubitemid 38552800)
42. B. Sheil, J. McCarthy, L. O'Mahony, M.W. Bennett, P. Ryan, J.J. Fitzgibbon, B. Kiely, J.K. Collins, and F. Shanahan Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis Gut 53 2004 694 700 (Pubitemid 38561448)
43. C. Picard, J. Fioramonti, A. Francois, T. Rpbinson, F. Neant, and C. Matuchansky Review article: bifidobacteria as probiotic agents - physiological effects and clinical benefits Aliment Pharmacol Ther 22 2005 495 512 (Pubitemid 41360796)
44. V. Lesniewska, I. Rowland, H.N. Laerke, G. Grant, and P.J. Naughton Relationship between dietary-induced changes in intestinal commensal microflora and duodenojejunal myoelectirc activity monitored by readiotelemetry in the rat in vivo Exp Physiol 91 2006 229 237
45. B. Wang, Y.-K. Mao, C. Diorio, M. Pasyk, R.Y. Wu, J. Bienenstock, and W.A. Kunze Luminal administration ex vivo of a live Lactobacillus species moderates mouse jejunal motility within minutes FASEB J 24 2010 4078 4088
46. D.M. Saulnier, F. Santos, S. Roos, T.-A. Mistretta, J.K. Spinler, D. Molenaar, B. Teusink, and J. Versalovic Exploring metabolic pathway reconstruction and genome-wide expression profiling in Lactobacillus reuteri to define functional probiotic features PLoS ONE 6 2011 e18783
47. M.E. Hibbing, C. Fuqua, M.R. Parsek, and S.B. Peterson Bacterial competition: surviving and thriving in the microbial jungle Nat Rev Microbiol 8 2010 15 25
48. A. Strocchi, and M.D. Levitt Factors affecting hydrogen production and consumption by human fecal flora J Clin Invest 89 1992 1304 1311
49. R.D. Heijtz, S. Wang, F. Anuar, Y. Qian, B. Björkholm, A. Samuelsson, M.L. Hibberd, H. Forssberg, and S. Pettersson Normal gut microbiota modulates brain development and behavior Proc Natl Acad Sci USA 108 2011 3047 3052
50. K.M. Neufeld, N. Kang, J. Bienenstock, and J.A. Foster Reduced anxiety-like behavior and central neurochemical change in germ-free mice Neurogastroenterol Motil 23 2011 255 264
51. J.F. Cryan, and S.M. O'Mahony The microbiome-gut-brain axis: from bowel to behavior Neurogastroenterol Motil 23 2011 187 192
52. M. Fleshner The gut microbiota: a new player in the innate immune stress response? Brain Behav Immun 25 2011 395 396
53. F. Shanahan Molecular mechanisms of probiotic action: it's all in the strains! Gut 60 2011 1026 1027
54. P. Van Baarlen, F.J. Troost, S. van Hemert, C. van der Meer, W.M. de Vos, P.J. de Groot, G.J.E.J. Hooiveld, R.-J.M. Brummer, and M. Kleerebezem Differential NF-κB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance PNAS 106 2009 2371 2376
55. I. Sekirov, S.L. Russell, L.C. Antunes, and B.B. Finlay Gut microbiota in health and disease Physiol Rev 90 2010 859 904
56. E. Isolauri, S. Salminen, and A.C. Ouwehand Microbial-gut interactions in health and disease. Probiotics Best Pract Res Clin Gastroenterol 18 2004 299 313
57. A.L. Engelbrektson, J.R. Korzenik, M.E. Sanders, B.G. Clement, G. Leyer, T.R. Klaenhammer, and C. Kitts Analysis of treatment effects on the microbial ecology of the human intestine FEMS Microbiol Ecol 57 2006 239 250 (Pubitemid 44024913)
58. L. Dethlefsen, and D.A. Relman Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation Proc Natl Acad Sci USA 108 Suppl. 1 2011 4554 4561
59. J. Neu, M. Mshvildadze, and V. Mai A roadmap for understanding and preventing necrotizing enterocolitis Curr Gastroenterol Rep 10 2008 450 457
60. E.M. Quigley, and A. Abu-Shanab Small intestinal bacterial overgrowth Infect Dis Clin North Am 24 2010 943 959
61. S. Vanner The small bowel intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment Gut 57 2008 1315 1321
62. D.N. Frank, A.L. St Amand, R.A. Feldman, E.C. Boedeker, N. Harpaz, and N.R. Pace Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases PNAS 104 2007 13780 13785 (Pubitemid 350003397)
63. R.B. Sartor Genetics and environmental interactions shape the intestinal microbiome to promote inflammatory bowel disease versus mucosal homeostasis Gastroenterology 139 2010 1816 1819
64. B.P. Willing, J. Dicksved, J. Halfvarson, A.F. Andersson, M. Lucio, Z. Zheng, G. Järnerot, C. Tysk, J.K. Jansson, and L. Engstrand A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes Gastroenterology 139 2010 1844 1854
65. G.W. Tannock The bowel microbiota and inflammatory bowel diseases Int J Inflamm 2010 954051
66. A.M. De Smet, J.A. Kluytmans, B.S. Cooper, E.M. Mascini, R.F. Benus, T.S. van der Werf, J.G. van der Hoeven, P. Pickkers, D. Bogaers-Hofman, and N.J. van der Meer Decontamination of the digestive tract and oropharynx in ICU patients N Engl J Med 360 2009 20 31
67. M. Gatt, B.S. Reddy, and J. Macfie Review article: bacterial translocation in the critically ill - evidence and prevention Aliment Pharmacol Ther 25 2007 741 757 (Pubitemid 46437210)
68. E.M. Quigley Passing the bug-Translocation, bacteremia, and sepsis in the intensive care unit patient: is intestinal decontamination the answer? Crit Care Med 39 2011 1202 1203
69. S. Asfaha, W.K. Macnaughton, C.B. Appleyard, K. Chadee, and J.L. Wallace Persistent epithelial dysfunction and bacterial translocation after resolution of intestinal inflammation Am J Physiol Gastrointest Liver Physiol 281 2001 G635 G644
70. H. Tilg, and A. Kaser Gut microbiome, obesity, and metabolic dysfunction J Clin Invest 121 2011 2126 2132
71. A. Abu-Shanab, and E.M. Quigley The role of the gut microbiota in nonalcoholic fatty liver disease Nat Rev Gastroenterol Hepatol 7 2010 691 701
72. R.E. Ley, F. Backhed, P. Turnbaugh, C.A. Lozupone, R.D. Knight, and J.I. Gordon Obesity alters gut microbial ecology Proc Natl Acad Sci USA 102 2005 11070 11075 (Pubitemid 41105994)
73. R.E. Ley, P.J. Turnbaugh, S. Klein, and J.I. Gordon Microbial ecology: human gut microbes associated with obesity Nature 444 2006 1022 1023 (Pubitemid 46018512)
74. P.J. Turnbaugh, R.E. Ley, M.A. Mahowald, V. Magrini, E.R. Mardis, and J.I. Gordon An obesity-associated gut microbiome with increased capacity for energy harvest Nature 444 2006 1027 1031 (Pubitemid 46018515)
75. P.J. Turnbaugh, F. Backhed, L. Fulton, and J.I. Gordon Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome Cell Host Microbe 3 2008 213 223 (Pubitemid 351494716)
76. R.E. Ley Obesity and the human microbiome Curr Opin Gastroenterol 26 2010 5 11
77. H. Zhang, J.K. DiBaise, A. Zuccolo, D. Kudrna, M. Braidotti, Y. Yu, P. Parameswaran, M.D. Crowell, R. Wing, B.E. Rittmann, and R. Krajmalnik-Brown Human gut microbiota in obesity and after gastric bypass Proc Natl Acad Sci USA 106 2009 2365 2370
78. K. Kotarsky, K.M. Sitnik, H. Stentsad, H. Kotarsky, A. Schmidtchen, M. Koslowski, J. Wehkamp, and W.W. Agace A novel role for constitutively expressed epithelial-derived chemokines as antibacterial peptides in the intestinal mucosa Mucosal Immunol 3 2010 40 48
79. E.F. Murphy, P.D. Cotter, S. Healy, T.M. Marques, O. O'Sullivan, F. Fouhy, S.F. Clarke, P.W. O'Toole, E.M. Quigley, C. Stanton, P.R. Ross, and R.M. O'Doherty The composition and energy harvesting capacity of the gut microbiota and their relationship to diet and obesity over time in mouse models Gut 59 2010 1635 1642
80. C. De Filippo, D. Cavalieri, M. Di Paola, M. Ramazzotti, J.B. Poullet, S. Massart, S. Collini, G. Pieraccini, and P. Lionetti Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa Proc Natl Acad Sci USA 107 2010 14691 14696
81. M.A. Hildebrandt, C. Hoffmann, S.A. Sherrill-Mix, S.A. Keilbaugh, M. Hamady, Y.Y. Chen, R. Knight, R.S. Ahima, F. Bushman, and G.D. Wu High-fat diet determines the composition of the murine gut microbiome independently of obesity Gastroenterology 137 2009 1716 1724
82. K.M. Maslowski, and C.R. Mackay Diet, gut microbiota and immune function Nat Immunol 12 2011 5 9
83. Z. Wang, E. Klipfell, B.J. Bennett, R. Koeth, B.S. Levison, B. Dugar, A.E. Feldstein, E.B. Britt, X. Fu, and Y.M. Chung Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease Nature 472 2011 57 63
84. S.H. Duncan, G.E. Lobley, G. Holtrop, J. Ince, A.M. Johnstone, P. Louis, and H.J. Flint Human colonic microbiota associated with diet, obesity and weight loss Int J Obesity 32 2008 1720 1724
85. J.K. DiBaise, H. Zhang, M.D. Crowell, R. Krajmalnik-Brown, G.A. Decker, and B.E. Rittmann Gut microbiota and its possible relationship with obesity Mayo Clin Proc 83 2008 460 469 (Pubitemid 351536471)
86. M.D. Spencer, T.J. Hamp, R.W. Reid, L.M. Fischer, S.H. Zeisel, and A.A. Fodor Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency Gastroenterology 140 2011 976 986
87. H. Kim, K. Kwack, D.-Y. Kim, and G.E. Ji Oral probiotic bacterial administration suppressed allergic responses in an ovalbumin-induced allergy mouse model FEMS Immunol Med Microbiol 45 2005 259 267 (Pubitemid 41040010)
88. M.H. Floch, W.A. Walker, S. Guandalini, P. Hibberd, S. Gorbach, C. Surawicz, M.E. Sanders, G. Garcia-Tsao, E.M. Quigley, and E. Isolauri Recommendations for probiotic use - 2008 J Clin Gastroenterol 42 Suppl. 2 2008 S104 S108
89. T. Jiang, and D.A. Savaiano Modification of colonic fermentation by Bifidobacteria and pH in vitro Dig Dis Sci 42 1997 2370 2377
90. I. Hojsak, S. Abdović, H. Szajewska, M. Milosević, Z. Krznarić, S. Kolacek, and G.G. Lactobacillus in the prevention of nosocomial gastrointestinal and respiratory tract infections Pediatrics 125 2010 e1171 e1177
91. G.A. Preidis, C. Hill, R.L. Guerrant, B.S. Ramakrishna, G.W. Tannock, and J. Versalovic Probiotics, enteric and diarrheal diseases, and global health Gastroenterology 140 2011 8 14
92. D.W. Thomas, F.R. Greer, American Academy of Pediatrics Committee on Nutrition, and American Academy of Pediatrics Section on Gastroenterology, Hepatology, and Nutrition Probiotics and prebiotics in pediatrics Pediatrics 126 2010 1217 1231
93. NASPGHAN Nutrition Report Committee, S. Michail, F. Sylvester, G. Fuchs, and R. Issenman Clinical efficacy of probiotics: review of the evidence with focus on children J Pediatr Gastroenterol Nutr 43 2006 550 557 (Pubitemid 44569023)
94. S.J. Allen, B. Okoko, E. Martinez, G. Gregorio, and L.F. Dans Probiotics for treating infectious diarrhoea Cochrane Database Syst Rev 2004 CD003048
95. A.L. D'Souza, C.H. Rajkumar, J. Cooke, and C.J. Bulpitt Probiotics in prevention of antibiotic associated diarrhea: meta-analysis BMJ 324 2002 1361 1366
96. L.V. McFarland Systematic review and meta-analysis of Saccharomyces boulardii in adult patients World J Gastroenterol 16 2010 2202 2222
97. B. Sheil, F. Shanahan, and L. O'Mahony Probiotic effects on inflammatory bowel disease J Nutr 137 2007 819S 824S (Pubitemid 46397524)
98. D. Damaskos, and G. Kolios Probiotics and prebiotics in inflammatory bowel disease: microflora "on the scope" Br J Clin Pharmacol 65 2008 453 467 (Pubitemid 351365144)
99. F. Shanahan Approaches that alter luminal contents and bacterial action T.M. Bayless, S.B. Hanauer, Advanced Therapy in Inflammatory Bowel Disease edn 3 2011 People's Medical Publishing House USA
100. G.A. Hecht Inflammatory bowel disease - live transmission New Engl J Med 358 2008 528 530
101. C. Grangette, S. Nutten, E. Palumbo, S. Morath, C. Hermann, J. Dewulf, B. Pot, T. Hartung, P. Hols, and A. Mercenier Enhanced antiinflammatory capacity of a Lactobacillus plantarum mutant synthesizing modified teichoic acids PNAS 102 2005 10321 10326 (Pubitemid 41023369)
102. E.M. Fernandez, V. Valenti, C. Rockel, C. Hermann, B. Pot, I.G. Boneca, and C. Grangette Anti-inflammatory capacity of selected of selected lactobacilli in experimental colitis is driven by NOD2-mediated recognition of a specific peptidoglycan-derived muropeptide Gut 60 2011 1050 1059
103. F. Yan, H. Cao, T.L. Cover, M.K. Washington, Y. Shi, L.S. Liu, R. Chaturvedi, R.M. Peek Jr. , K.T. Wilson, and D.P. Polk Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism J Clin Invest 121 2011 2242 2253
104. E. Heuvelin, C. Lebreton, C. Grangette, B. Pot, N. Cerf-Bensussan, and M. Heyman Mechanisms involved in alleviation of intestinal inflammation by Bifidobacterium breve soluble factors PLoS ONE 4 2009 e5184
105. B. Foligne, G. Zoumpopoulou, J. Dewulf, A.B. Younes, F. Chareye, J.-C. Sirard, B. Pot, and C. Grangette A key role for dendritic cells in probiotic functionality PLoS ONE 3 2007 e313
106. S. Ulisse, P. Gionchetti, S. D'Alo, F.P. Russo, I. Pesce, G. Ricci, F. Rizzello, U. Helwig, M.G. Cifone, M. Campieri, and C. De Simone Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment Am J Gastroenterol 96 2001 2691 2699
107. R.B. Sartor, and M. Muehlbauer Microbial host interactions in IBD: implications for pathogenesis and therapy Curr Gastroenterol Rep 9 2007 497 507 (Pubitemid 351795708)
108. J.B. Ewaschuk, Q.Z. Tejpar, I. Soo, K. Madsen, and R.N. Fedorak The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease Curr Gastroenterol Rep 8 2006 486 498 (Pubitemid 46017161)
109. T. Mimura, F. Rizzello, U. Helwig, G. Poggioli, S. Schreiber, I.C. Talbot, R.J. Nicholls, P. Gionchetti, M. Campieri, and M.A. Kamm Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis Gut 53 2004 108 114 (Pubitemid 38083018)
110. H.C. Lin, C.H. Hsu, H.L. Chen, M.Y. Chung, J.F. Hsu, R.I. Lien, L.Y. Tsao, C.H. Chen, and B.H. Su Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial Pediatrics 122 2008 693 700
111. C. Manichanh, E. Varela, C. Martinez, M. Antolin, M. Llopis, J. Dore, J. Giralt, F. Guarner, and J.-R. Malagelada The gut microbiota predispose to the pathophysiology of acute postradiotherapy diarrhea Am J Gastroenterol 103 2008 1754 1761
112. E.M.M. Quigley Bacteria: a new player in gastrointestinal motility disorders - infections, bacterial overgrowth and probiotics Gastroenterol Clin N Am 36 2007 735 748 (Pubitemid 47575843)
113. A.M. Schoepfer, T. Schaffer, B. Seibold-Schmid, S. Muller, and F. Seibold Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients Neurogastroenterol Motil 20 2008 1110 1118
114. S.M. Ivison, and T.S. Steiner Anti-falgellin antibodies in irritable bowel syndrome: another attack on our commensals Neurogastroenterol Motil 20 2008 1081 1085
115. C.L. Frissora, and B.D. Cash Review article: the role of antibiotics vs. conventional pharmacotherapy in treating symptoms of irritable bowel syndrome Aliment Pharamacol Ther 25 2007 1271 1281 (Pubitemid 46763454)
116. G. Barbara, V. Stanghellini, G. Brandi, C. Cremon, G. Di Nardo, R. De Giorgio, and R. Corinaldesi Interactions between commensal gut flora and gut sensorimotor function in health and disease Am J Gastroenterol 100 2005 2560 2568
117. L. Desbonnet, L. Garrett, G. Clarke, J. Bienenstock, and T.G. Dinan The probiotic Bifidobacterium infantis: an assessment of potential antidepressant properties in the rat J Psychiatr Res 43 2008 164 174
118. L. Desbonnet, L. Garrett, G. Clarke, B. Kiely, J.F. Cryan, and T.G. Dinan Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression Neuroscience 170 2010 1179 1188
119. D.P. McKernan, P. Fitzgerald, T.G. Dinan, and J.F. Cryan The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat Neurogastroenterol Motil 22 2010 1029 1035
120. J. Zeng, Y.-Q. Li, X.-L. Zuo, Y.-B. Zhen, J. Yang, and C.-H. Liu Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome Aliment Pharmacol Ther 28 2008 994 1002
121. C. Rousseaux, X. Thuru, A. Gelot, N. Barnich, C. Neut, L. Dubuquoy, C. Dubuquoy, E. Merour, K. Geboes, and M. Chamaillard Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors Nat Med 13 2007 35 37 (Pubitemid 46067383)
122. E.F. Verdu, P. Bercik, G.E. Bergonzelli, X.-X. Huang, P. Blenerhasset, F. Rochat, M. Fiaux, R. Mansourian, I. Corthesy-Theulaz, and S.M. Collins Lactobacillus paracasei normalizes muscle hypercontractility in a murine model of postinfective gut dysfunction Gastroenterology 127 2004 826 837 (Pubitemid 39208415)
123. E.F. Verdu, P. Bercik, M. Verma-Gandhu, X.-X. Huang, P. Blenerhasset, W. Jackson, Y. Mao, L. Wang, F. Rochat, and S.M. Collins Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice Gut 55 2006 182 190 (Pubitemid 43117275)
124. T. Kamiya, L. Eang, P. Forsythe, G. Goettsche, Y. Mao, Y. Wang, G. Tougas, and J. Bienenstock Inhibitory effects of Lactobacillus reuteri on visceral pain induced by colorectal distension in Sprague-Dawley rats Gut 55 2006 191 196 (Pubitemid 43117276)
125. N. Valeur, P. Engel, N. Carbajal, E. Connolly, and K. Ladefoged Colonization and immunomodulation by Lactobacillus reuteri ATCC 55730 in the human gastrointestinal tract Appl Environ Mocrobiol 70 2004 1176 1181 (Pubitemid 38568246)
126. S.C. Duncker, L. Wang, P. Hols, and J. Bienenstock The d-alanine content of lipotechoic acid is crucial for Lactobacillus plantarum-mediated protection from visceral pain perception in a rat colorectal distension model Neurogastroenterol Motil 20 2008 843 850 (Pubitemid 351814385)
127. S.M. Collins The immunomodulation of enteric neuromuscular function: implications for motility and inflammatory disorders Gastroenterology 111 1996 1683 1699 (Pubitemid 26404236)
128. W.I. Khan, and S.M. Collins Gut motor inflammation: immunological control in enteric infection and inflammation Clin Exp Immunol 143 2005 389 397
129. F.-P.J. Martin, E.F. Verdu, Y. Yang, M.-E. Dumas, I.K.S. Yap, O. Cloarec, G.E. Bergonzelli, I. Corthesy-Theulaz, S. Kochhar, and E. Holmes Transgenomic metabolic interactions in a mouse model: interaction of Trichinella spiralis infection with dietary Lactobacillus paracasei supplementation J Proteome Res 5 2006 2185 2193 (Pubitemid 44330811)
130. E.M.M. Quigley, and B. Flourie Probiotics in irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date Neurogastroenterol Motil 19 2007 166 172 (Pubitemid 46239427)
131. E.A. Williams, J. Stimpson, D. Wang, S. Plummer, I. Garaiova, M.E. Barker, and B.M. Corfe Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled trial Aliment Pharmcol Ther 29 2009 97 103
132. D.H. Sinn, J.H. Song, H.J. Kim, J.H. Lee, H.J. Son, D.K. Chang, Y.-H. Kim, J.J. Kim, J.C. Rhee, and P.-Y. Rhee Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome Dig Dis Sci 53 2008 2714 2718
133. D.M. Brenner, M.J. Moeller, W.D. Chey, and P.S. Schoenfeld The utility of probiotics in the treatment of irritable bowel syndrome: a systematic review Am J Gastroenterol 104 2009 1033 1049
134. P. Moayyedi, A.C. Ford, N.J. Talley, F. Cremonini, A. Foxx-Orenstein, L. Brandt, and E. Quigley The efficacy of probiotics in the therapy of irritable bowel syndrome: a systematic review Gut 59 2010 325 332
135. L. O'Mahony, J. McCarthy, P. Kelly, G. Hurley, F. Luo, K. Chen, G.C. O'Sullivan, B. Kiely, J.K. Collins, and F. Shanahan A Randomized, placebo-controlled, double-blind comparison of the probiotic bacteria lactobacillus and bifidobacterium in irritable bowel syndrome (IBS): symptom responses and relationship to cytokine profiles Gastroenterology 128 2005 541 551 (Pubitemid 40585355)
136. P.J. Whorwell, L. Altringer, J. Morel, Y. Bond, D. Charbonneau, L. O'Mahony, B. Kiely, B. Shanahan, and E.M. Quigley Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome Am J Gastroenterol 101 2006 326 333
137. S. Drouault-Holowacz, S. Bieuvelet, A. Burckel, M. Cazaubiel, X. Dray, and P. Marteau A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome Gastroenterol Clin Biol 32 2008 147 152 (Pubitemid 351637577)
138. M. Simrén, L. Ohman, J. Olsson, U. Svensson, K. Ohlson, I. Posserud, and H. Strid Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study Aliment Pharmacol Ther 31 2010 218 227
139. A. Agrawal, L.A. Houghton, J. Morris, B. Reilly, D. Guyonnet, N. Goupil Feuillerat, A. Schlumberger, S. Jakob, and P.J. Whorwell Clinical trial: the effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation Aliment Pharmacol Ther 29 2009 104 114
140. D. Guyonnet, A. Schlumberger, L. Mhamdi, S. Jakob, and O. Chassany Fermented milk containing Bifidobacterium lactis DN-173 010 imporves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomized, double-blind, parallel, controlled trial Br J Nutr 102 2009 1654 1662
141. A. Bonetti, L. Morelli, and E. Campominosi Assessment of the persistence in the human intestinal tract of two probiotic lactobacilli Lactobacillus salivarius I 1974 and Lactobacillus paracasei I 1688 Microbiol Ecol Health Dis 14 2002 228 232 (Pubitemid 36222183)
142. P.W. O'Toole, and J.C. Cooney InterProbiotic bacteria influence the composition and function of the intestinal microbiota.discip Perspect Infect Dis 2008 2008 175285
143. F. Shanahan Probiotics: a perspective on problems and pitfalls Scand J Gastroenterol 38 Suppl. 2003 34 36 (Pubitemid 36609877)
144. R.J. Boyle, R.M. Robins-Browne, and M.L.K. Tang Probiotic use in clinical practice: what are the risks? Am J Clin Nutr 83 2006 1256 1264 (Pubitemid 44713053)
145. A. Ohishi, S. Takahashi, Y. Ito, Y. Ohishi, K. Tsukamoto, Y. Nanba, N. Ito, S. Kakiuchi, A. Saitoh, and M. Morotomi Bifidobacterium septicemia associated with postoperative probiotic therapy in a neonate with omphalocele J Pediatr 156 2010 679 681
146. M.G. Besselink, H.C. van Santvoort, E. Buskens, M.A. Boermeester, H. van Goor, H.M. Timmerman, V.B. Nieuwenhuijs, T.L. Bollen, B. van Ramshorst, and B.J. Witteman Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial Lancet 371 2008 651 659
147. M.E. Sanders, L.M.A. Akkermans, D. Haller, C. Hammerman, J. Heimbach, G. Hormannsperger, G. Huys, D.D. Levy, F. Lutgendorff, and D. Mack Safety assessment of probiotics for human use Gut Microbes 1 2010 164 185
148. A.M. O'Hara, and F. Shanahan The gut flora as a forgotten organ EMBO Rep 7 2006 688 693 (Pubitemid 43986264)
149. P.W. O'Toole, and M.J. Claesson Gut microbiota: changes throughout the lifespan from infancy to elderly Int Dairy J 20 2010 281 291
150. E.M.M. Quigley The future of probiotics S. Michail, P. Sherman, Probiotics in Pediatric Medicine 2008 Humana Press Totowa, NJ 323 329
151. G. Reid, E. Gaudier, F. Guarner, G.B. Huffnagle, J.M. Macklaim, A.M. Munoz, M. Martini, T. Ringel-Kulka, B.R. Sartor, and R.R. Unal Responders and non-responders to probiotic interventions. How can we improve the odds? Gut Microbes 1 2010 200 204
152. A.M. O'Hara, P. O'Regan, A. Fanning, C. O'Mahony, J. Macsharry, A. Lyons, J. Bienenstock, L. O'Mahony, and F. Shanahan Functional modulation of human intestinal epithelial cell responses by Bifidobacterium infantis and Lactobacillus salivarius Immunology 118 2006 202 215 (Pubitemid 43727425)